Return On Assets in % of INTEGRATED BIOPHARMA INC from Q1 2012 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Integrated Biopharma Inc quarterly/annual Return On Assets history and change rate from Q1 2012 to Q3 2025.
  • Integrated Biopharma Inc Return On Assets for the quarter ending 30 Sep 2025 was 2.64 %, a 61.1% increase year-over-year.
  • Integrated Biopharma Inc annual Return On Assets for 2025 was 3.16 %, a 643% increase from 2024.
  • Integrated Biopharma Inc annual Return On Assets for 2024 was 0.42 %.
  • Integrated Biopharma Inc annual Return On Assets for 2023 was -0.13 %, a 101% decline from 2022.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

INTEGRATED BIOPHARMA INC Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 2.64 +1 +61.1% 01 Jul 2025 30 Sep 2025
Q2 2025 3.16 +2.73 +643% 01 Apr 2025 30 Jun 2025
Q1 2025 4.84 +5.28 01 Jan 2025 31 Mar 2025
Q4 2024 3.54 +5 01 Oct 2024 31 Dec 2024
Q3 2024 1.64 +1.86 01 Jul 2024 30 Sep 2024
Q2 2024 0.42 +0.55 01 Apr 2024 30 Jun 2024
Q1 2024 -0.44 -5.87 -108% 01 Jan 2024 31 Mar 2024
Q4 2023 -1.46 -9.82 -118% 01 Oct 2023 31 Dec 2023
Q3 2023 -0.22 -12.6 -102% 01 Jul 2023 30 Sep 2023
Q2 2023 -0.13 -14.8 -101% 01 Apr 2023 30 Jun 2023
Q1 2023 5.43 -20.8 -79.3% 01 Jan 2023 31 Mar 2023
Q4 2022 8.36 -20 -70.5% 01 Oct 2022 31 Dec 2022
Q3 2022 12.4 -17.3 -58.3% 01 Jul 2022 30 Sep 2022
Q2 2022 14.7 -16.9 -53.4% 01 Apr 2022 30 Jun 2022
Q1 2022 26.2 +4.36 +20% 01 Jan 2022 31 Mar 2022
Q4 2021 28.3 +6.51 +29.8% 01 Oct 2021 31 Dec 2021
Q3 2021 29.6 +7.67 +35% 01 Jul 2021 30 Sep 2021
Q2 2021 31.6 +11.8 +60% 01 Apr 2021 30 Jun 2021
Q1 2021 21.9 +9.03 +70.4% 01 Jan 2021 31 Mar 2021
Q4 2020 21.8 +9.31 +74.4% 01 Oct 2020 31 Dec 2020
Q3 2020 21.9 +13.2 +151% 01 Jul 2020 30 Sep 2020
Q2 2020 19.8 +11.7 +147% 01 Apr 2020 30 Jun 2020
Q1 2020 12.8 +1.97 +18.2% 01 Jan 2020 31 Mar 2020
Q4 2019 12.5 +3.5 +38.8% 01 Oct 2019 31 Dec 2019
Q3 2019 8.74 +2.44 +38.7% 01 Jul 2019 30 Sep 2019
Q2 2019 8.01 +3.34 +71.6% 01 Apr 2019 30 Jun 2019
Q1 2019 10.9 01 Jan 2019 31 Mar 2019
Q4 2018 9.01 01 Oct 2018 31 Dec 2018
Q3 2018 6.3 01 Jul 2018 30 Sep 2018
Q2 2018 4.67 01 Apr 2018 30 Jun 2018
Q1 2016 0.78 -4.96 -86.3% 01 Jan 2016 31 Mar 2016
Q4 2015 -0.29 -3.46 -109% 01 Oct 2015 31 Dec 2015
Q3 2015 4.6 +2.59 +128% 01 Jul 2015 30 Sep 2015
Q2 2015 5.78 +4.65 +410% 01 Apr 2015 30 Jun 2015
Q1 2015 5.75 -2.93 -33.8% 01 Jan 2015 31 Mar 2015
Q4 2014 3.17 -4.42 -58.2% 01 Oct 2014 31 Dec 2014
Q3 2014 2.02 -8.57 -80.9% 01 Jul 2014 30 Sep 2014
Q2 2014 1.13 +0.41 +56.3% 01 Apr 2014 30 Jun 2014
Q1 2014 8.67 +26.5 01 Jan 2014 31 Mar 2014
Q4 2013 7.59 +27.8 01 Oct 2013 31 Dec 2013
Q3 2013 10.6 +45.5 01 Jul 2013 30 Sep 2013
Q2 2013 0.73 +23.5 01 Apr 2013 30 Jun 2013
Q1 2013 -17.8 -0.43 -2.48% 01 Jan 2013 31 Mar 2013
Q4 2012 -20.2 01 Oct 2012 31 Dec 2012
Q3 2012 -35 01 Jul 2012 30 Sep 2012
Q2 2012 -22.8 01 Apr 2012 30 Jun 2012
Q1 2012 -17.4 01 Jan 2012 31 Mar 2012

INTEGRATED BIOPHARMA INC Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2025 3.16 +2.73 +643% 01 Jul 2024 30 Jun 2025
2024 0.42 +0.55 01 Jul 2023 30 Jun 2024
2023 -0.13 -14.8 -101% 01 Jul 2022 30 Jun 2023
2022 14.7 -16.9 -53.4% 01 Jul 2021 30 Jun 2022
2021 31.6 +11.8 +60% 01 Jul 2020 30 Jun 2021
2020 19.8 +11.7 +147% 01 Jul 2019 30 Jun 2020
2019 8.01 +3.34 +71.6% 01 Jul 2018 30 Jun 2019
2018 4.67 +5.64 01 Jul 2017 30 Jun 2018
2017 -0.97 -7.2 -116% 01 Apr 2017 31 Mar 2018
2016 6.23 +0.44 +7.61% 01 Apr 2016 31 Mar 2017
2015 5.78 +4.65 +410% 01 Jul 2014 30 Jun 2015
2014 1.13 +0.41 +56.3% 01 Jul 2013 30 Jun 2014
2013 0.73 +23.5 01 Jul 2012 30 Jun 2013
2012 -22.8 01 Jul 2011 30 Jun 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.